Abnormal FGFR 3 expression in cartilage of thanatophoric dysplasia fetuses

Human Molecular Genetics

Volumn 6, Issue 11, 1997, Pages 1899-1906

  Delezoide, Anne Lise ^a   Lasselin Benoist, Catherine ^a   Legeai Mallet, Laurence ^a   Brice, Peggy ^a   Senée, Valérie ^a   Yayon, Avner ^b   Munnich, Arnold ^a   Vekemans, Michel ^a   Bonaventure, Jacky ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COLLAGEN TYPE 10; FIBROBLAST GROWTH FACTOR RECEPTOR; MESSENGER RNA;

ARTICLE; CARTILAGE; CARTILAGE CELL; CELL NUCLEUS; CELL PROLIFERATION; FETUS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; THANATOPHORIC DWARFISM;

CARTILAGE; CHONDROCYTES; EMBRYONIC AND FETAL DEVELOPMENT; FETAL DISEASES; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GROWTH PLATE; HUMANS; MUTATION; PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR; RNA, MESSENGER; THANATOPHORIC DYSPLASIA;

EID: 0030778492     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/6.11.1899     Document Type: Article

References (31)

1. Rousseau,F., Bonaventure,J., Legeai-Mallet,L., Pelet,A., Rozet,J.M., Maroteaux,P., Le Merrer,M. and Munnich,A. (1994) Mutations in the gene encoding fibroblast growth factor receptor 3 in achondroplasia. Nature, 371, 252-254.
2. Shiang,R., Thompson,L.M., Zhu,Y.Z., Church,D.M., Fielder,T.J., Bocian,M., Winokur,S.T. and Wasmuth,J.J. (1994) Mutations in the transmembrane domain of FGFR 3 cause the most common genetic form of dwarfism achondroplasia. Cell, 78, 336-342.
3. Bellus,G.A., McIntosh,I., Smith,A.E., Aylsworth,A.S., Kaitila,I., Horton,W., Greenhaw,G.A., Hecht,J.T. and Francomano,C. (1995) A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nature Genet., 10, 357-359.
4. Rousseau,F., Saugier,P., Le Merrer,M., Munnich,A., Delezoide,A.L., Maroteaux,P. and Bonaventure,J. (1995) Stop codon FGFR 3 mutations in thanatophoric dwarfism type I. Nature Genet., 10, 11-12.
5. Tavormina,P.L., Shiang,R., Thompson,L., Zhu,Y.Z., Wilkin,D.J., Lachman,R., Wilcox,W.R., Rimoin,D., Cohn,D. and Wasmuth,J.J. (1995) Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nature Genet., 9, 321-328.
6. Meyers,G.A., Orlow,S.J., Munro,I.R., Przylepa,K.A. and Jabs,E.W. (1995) Fibroblast growth factor receptor 3 (FGFR 3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nature Genet., 11, 462-464.
7. Bellus,G.A. Gaudenz,K., Zackai,E.H., Clarke,L.A., Szabo,J., Francomano,C. and Muenke,M. (1996) Identical mutations in three fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nature Genet., 14, 174-176.
8. Webster,M. and Donoghue,D.J. (1996) Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J., 15, 520-527.
9. Naski,M.C., Wang,Q., Xu,J. and Ornitz,D. (1996) Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nature Genet., 13, 233-237.
10. Webster,M.K., d'Avis,P.Y., Robertson,S.C. and Donoghue,D.J. (1996) Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol. Cell. Biol., 16, 4081-4087.
11. Peters,K., Ornitz,D., Wemer,S. and Williams,L. (1993) Unique expression of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol., 155, 423-430.
12. Deng,C., Wynshaw-Boris,A., Zhou,F., Kuo,A. and Leder,P. (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell, 84, 911-921.
13. Wuechner,C., Sandberg Nordqvist,A.-C., Winterpacht,A., Zabel,B. and Schalling,M. (1996) Developmental expression of splicing variants of fibroblast growth factor receptor 3 (FGFR 3) in mouse. Int. J. Dev. Biol., 40, 1185-1188.
14. Werner,S., Weinberg,W., Liao,X., Peters,K., Blessing,M., Yuspa,S.H., Weiner,R.L. and Williams,L. (1993) Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO J., 12, 2635-2643.
15. Chellaiah,A., Mc Ewen,D.G., Werner,S., Xu,J. and Ornitz,D. (1994) Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J. Biol. Chem., 269, 11620-11627.
16. Scotet,E. and Houssaint,E. (1995) The choice between alternative IIIb and IIIc exons of the FGFR-3 gene is not strictly tissue-specific, Biochim. Biophys. Acta, 1264, 238-242.
17. Avivi,A., Yayon,A. and Givol,D. (1993) A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III. FEBS Lett., 330. 249-252.
18. Orr-Urtreger,A., Givol,D., Yayon,A., Yarden,Y. and Lonai,P. (1991) Developmental expression of two murine fibroblasts growth factor receptors fig and bek. Development, 113, 1419-1434.
19. Peters,K.G., Werner,S., Chen,G. and Williams,L.T. (1992) Two FGFreceptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development, 114, 233-243.
20. Patstone,G., Pasquale,E.B. and Maher,P.A. (1993) Differrent members of the fibroblast growth factor receptor family are specific to distinct cell types in the developing chicken embryo. Dev Biol., 155, 107-123.
21. Itoh,N., Mima,T. and Mikawa,T. (1996) Loss of fibroblast growth factor receptors is necessary for terminal differentiation of embryonic limb muscle. Development, 122, 291-300.
22. Prudovsky,I., Savion,N., Zhan,X., Friesel,R., Xu,J., Hou,J., McKeehan,W.L. and Maciag,T (1994) Intact and functional fibroblast growth factor (FGF) receptor 1 trafficks near the nucleus in response to FGF-1. J. Biol. Chem., 269, 31720-31724.
23. Maher,P.A. (1996) Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF 2. J. Cell Biol., 134, 529-536.
24. Kato,Y. and Iwamoto,M. (1990) Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. J. Biol. Chem., 265, 5903-5909.
25. Amling,M., Neff,L., Tanaka,S., Inoue,D., Kuida,K., Weir,E., Philbrick,W.M., Broadus,A.E. and Baron,R. (1997) Bcl 2 lies downstream of parathyroid hormone related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J. Cell Biol., 136, 205-213.
26. Rousseau,F., El Ghouzzi,V., Delezoide,A.L., Legeai-Mallet,L., Le Merrer,M., Munnich,A. and Bonaventure,J. (1996) Missense FGFR 3 mutations create cysteine residues in thanatophoric dwarfism type 1 (TD 1). Hum. Mol. Genet., 5, 509-512.
27. Bonaventure,J., Rousseau,F., Legeai-Mallet,L., Le Merrer,M., Munnich,A. and Maroteaux,P. (1996) Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia and thanatophoric dwarfism. Am. J. Med. Genet., 63, 148-154.
28. Johnston,C.L., Cox,H.C., Gomm,J. and Coombes,R.C. (1995) Fibroblast growth factor receptors (FGFRs) localize in different cell compartment. A splice variant of FGFR 3 localizes to the nucleus. J. Biol. Chem., 276, 30643-30650.
29. Keegan,K., Johnson,D., Williams,L. and Hayman,M. (1991) Isolation of an additional member of the fibroblast growth factor receptor family, FGFR 3. Proc. Natl. Acad. Sci. USA, 88, 1095-1099.
30. Isacchi,A., Bergonzoni,L. and Sarmientos,P. (1990) Complete sequence of a human receptor for acidic and basic fibroblast growth factors. Nucleic Acid Res., 18, 1906.
31. Thomas,J.T., Cresswell,C.J., Rash,B., Nicolai,H., Jones,T., Salomon,E., Grant,M.E. and Boot-Hanford,R.P. (1991) The human collagen X gene. Complete primary translated sequence and chromosomal localization. Biochem. J., 280, 141-148.